FOU Nevroklinikken

Research and development on musculoskeletal health and neuroscience,
Division of Clinical Neuroscience, Oslo University Hospital

[FOU Nevroklinikken @FOU_Nevroklin]

Vi søker en forskningskoordinator/studie-sykepleier til Seksjon for kliniske studier ved FoU: https://t.co/yQVkExNVXF

[FOU Nevroklinikken @FOU_Nevroklin]

The #GeNeup project is nearing completion! We've collected high-quality data from over 2500 patients and bloodwork from almost 1200 at five Norwegian university hospitals. We're now performing genomic analyses to look for underlying mechanisms of #neuropathicpain.

[FOU Nevroklinikken @FOU_Nevroklin]

Vil du bidra til framtidens hjerneforskning? Vi søker en rådgiver til Nevrovit for å jobbe med pasientregistre og forskningsbiobank. En unik mulighet til å sikre kvalitet og fremragende forskning! Les mer og søk her:https://t.co/DOQbqWFSgg #Hjerneforskning #Jobbmulighet #NevroVit

[Morgenbladet @Morgenbladet]

Hvor sterk smerte du kjenner, avhenger av hva slags kjønn du har. – Kvinner kan ha blitt overmedisinert med medikamenter som kanskje egentlig ikke fungerer på dem, sier forsker Maria Dehli Vigeland. (M+) https://t.co/VBeS8Kea9j

[FOU Nevroklinikken @FOU_Nevroklin]

Nevrovitenskapelig register og forskningsbiobank er et flaggskip for kvalitet og forskning ved @Oslounivsykehus. For å sikre høy kvalitet og god utvikling har vi nå hatt "audit" med ressurspersoner fra Biobank Norge: Liv Paltiel, Jeanette Aarem og Solveig Kvam. @Biobanken

[Kristian Bernhard Nilsen @BernhardNilsen]

One of the most downloaded papers in Muscle & Nerve last year was our paper "Which combined nerve conduction study scores are best suited for polyneuropathy in diabetic patients?". Really inspiring!
https://t.co/xXs7vt1Yqp
@nevfys @ResearchNeurOUS @FOU_nevroklin

[Oslounivsykehus @Oslounivsykehus]

Ungdommer med traumatiske opplevelser bruker mer smertestillende medisiner enn de som ikke har slike opplevelser.
https://t.co/mZnVtsIc0g
@FOU_Nevroklin @NKVTS @theHUNTstudy
#traumebevisstomsorg #ungdomshelse #hodepine #muskelskjelett

[FOU Nevroklinikken @FOU_Nevroklin]

Warm welcome to Hildegunn and Kristine, two Bachelor students from OsloMet contributing to a research project in the project group of Kaja Nordengen @hjerneforskeren. Here under supervision of Chiara Cappelletti and master student Martine Narum @oslomet @ResearchNeurOUS

[FOU Nevroklinikken @FOU_Nevroklin]

We are happy to welcome Chiara Cappelletti as special engineer in the Neuroscience Research Unit laboratory. Together with @ToneBerge5 and @lmp020870, she will run out lab and contribute in different projects for the Division of Neuroscience @ResearchNeurOUS

[FOU Nevroklinikken @FOU_Nevroklin]

FoU og Norsk senter for hodepineforskning @NorHEADresearch, gjennomfører nå studien #BioCer, en klinisk studie som undersøker ny forebyggende behandling for migrene: Medikamentfri behandling med biofeedback. Drives av NorHEAD, NTNU, St. Olavs hospital og Ahus.

[FOU Nevroklinikken @FOU_Nevroklin]

Fokus på pasientsikkerhet med kurs i Hjerte-lunge redning for alle ansatte ved FoU ♥️🧑‍⚕️

[FOU Nevroklinikken @FOU_Nevroklin]

We are close to the end of the #MultipleMS project (EU Horizon project) and have many results to discuss. This year we met in Amsterdam for our annual general assembly.  @ResearchNeurOUS @ToneBerge5 #HorizonEU

[FOU Nevroklinikken @FOU_Nevroklin]

Fantastic to again join a conference in person! @ToneBerge5 from FoU and several MS researcher from the Dept of Neurology, Oslo University Hospital are present in Amsterdam on #ECTRIMS2022. This year there are 7000 participants in Amsterdam and 2000 joining digitally.

[FOU Nevroklinikken @FOU_Nevroklin]

PhD student Chiara Cappelletti is presenting her on transcriptomic analysis of brain tissue in Parkinsons' disease at a genetic conference in Los Angeles arranged by the American Society of Human Genetics #ASHG2022

[FOU Nevroklinikken @FOU_Nevroklin]

Newly published research using MRI data on patients with #lowbackpain and #Modicchanges from the #AIMstudy

[Lars Chr Bråten @LarsChrBraten]

Diffusion weighted MRI with apparent diffusion coefficient (ADC)-measurements can be useful to assess in patients with low back pain and Modic changes
https://t.co/wobVvCVURt

[FOU Nevroklinikken @FOU_Nevroklin]

Researchers from our department contributed to a the largest genetic study of stroke to date, publ in Nature 30 Sept. The study identifies potential novel drug targets, and for the first time maps genetic risk for stroke across non-European populations. https://t.co/YXq9uytGUc

[FOU Nevroklinikken @FOU_Nevroklin]

Newly published research from our postdoc Lars Christian Bråten on "minimal important change" in pain among low back pain patients:

[Lars Chr Bråten @LarsChrBraten]

Minimal Important Change was on the lower spectrum of previous estimates and Responsiveness was sufficient for core outcomes in chronic low back pain
https://t.co/0cwELM4Dsm

[FOU Nevroklinikken @FOU_Nevroklin]

Vi lærer av de beste! Dag O. Hessen @daghes og Anne Spurkland @anspurk glimrende om forskningsformidling på oppstartsseminar med #REMEDY, Forskningssenter for behandling innen revmatologi og muskelskjelettsykdommer.

[FOU Nevroklinikken @FOU_Nevroklin]

The final patient included in the researcher-initiated NOR-MS study (Norwegian study of Oral cladribine and Rituximab in MS). 264 patients will be followed for 2 yrs. @OwrenGro @hjernelegen @HanneFH1 @ToneBerge5 @CeliusElisabeth @ResearchNeurOUS @Dr_Overas https://t.co/e1Vpb2SXqs

[FOU Nevroklinikken @FOU_Nevroklin]

As part of the Norwegian Headache Research Centre (NorHEAD), our department will contribute to new and improved treatment for headache disorders. NorHEAD is a Centre for Clinical Treatment Research, funded by the Research Council of Norway @NorHEADresearch @forskningsradet